NCT06766357View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2026

Conditions
Moderate to Severe Dry Eye
Interventions
DRUG

Cyclosporine ophthalmic gel

Administer to eyes

DRUG

Cyclosporine ophthalmic gel vehicle

Administer to eyes

Trial Locations (1)

Unknown

RECRUITING

Xiamen Eye Center of Xiamen University, Xiamen

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY